EGFR
EGFR (epidermal growth factor receptor) inhibitors are compounds that block the signaling of EGFR, a receptor that is often overexpressed in various cancers and plays a critical role in angiogenesis. EGFR inhibitors are used to prevent tumor growth and metastasis by disrupting the pathways that promote blood vessel formation in tumors. These inhibitors are widely used in cancer research and therapy. At CymitQuimica, we offer a diverse selection of high-quality EGFR inhibitors to support your research in oncology and angiogenesis.
Read more
MAPK-IN-2
MAPK-IN-2 (compound 3h) is an efficacious MAPK inhibitor with antineoplastic properties that significantly hinders proliferation …
Formula:
C20H11Cl2N3O
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
380.23
Ref: TM-T79572
| 5mg | 922.00 € | ||
| 25mg | 1,539.00 € | ||
| 50mg | 2,303.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025
Icotinib Hydrochloride
CAS:1204313-51-8
Icotinib Hydrochloride, an oral EGFR inhibitor (BPI-2009H), may halt cancer growth by blocking EGFR signaling.
Formula:
C22H22ClN3O4
Purity:
99.77%
Color and Shape:
Solid
Molecular weight:
427.88
Ref: TM-T2307
| 5mg | 60.00 € | ||
| 10mg | 88.00 € | ||
| 25mg | 140.00 € | ||
| 50mg | 227.00 € | ||
| 100mg | 338.00 € | ||
| 200mg | 500.00 € | ||
| 1mL*10mM (DMSO) | 66.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025
Tyrphostin A25
CAS:118409-58-8
Tyrphostin A25 (Tyrphostin AG 82) is a specific EGFR tyrosine kinase inhibitor and GPR35 agonist …
Formula:
C10H6N2O3
Purity:
98.76%
Color and Shape:
Yellow Green Powder /Off-White Solid
Molecular weight:
202.17
Ref: TM-T21622
| 2mg | 39.00 € | ||
| 5mg | 57.00 € | ||
| 10mg | 82.00 € | ||
| 25mg | 120.00 € | ||
| 50mg | 172.00 € | ||
| 100mg | 255.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EGFR-IN-99
CAS:2068806-31-3
EGFR-IN-99 (JBJ-03-142-02) is an EGFR and HER2 Exon 20 insertion mutation inhibitor for the study …
Formula:
C25H22FN7O3
Purity:
97.75%
Color and Shape:
Liquid
Molecular weight:
487.49
Ref: TM-T35901
| 1mg | 127.00 € | ||
| 5mg | 303.00 € | ||
| 10mg | 449.00 € | ||
| 25mg | 727.00 € | ||
| 50mg | 998.00 € | ||
| 100mg | 1,349.00 € | ||
| 500mg | 2,688.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EGFR-IN-2
CAS:1643497-70-4
EGFR-IN-2 is a non-covalent, mutation-selective and irreversible second-generation EGFR inhibitor.
Formula:
C26H33N9O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
551.66
Ref: TM-T11159
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Falnidamol
CAS:196612-93-8
Falnidamol (BIBX 1382), an oral selective EGFR inhibitor, IC50 3 nM, weak on ErbB2 and …
Formula:
C18H19ClFN7
Purity:
96.46%
Color and Shape:
Solid
Molecular weight:
387.84
Ref: TM-TQ0271
| 2mg | 42.00 € | ||
| 5mg | 64.00 € | ||
| 10mg | 101.00 € | ||
| 25mg | 192.00 € | ||
| 50mg | 335.00 € | ||
| 100mg | 462.00 € | ||
| 200mg | 645.00 € | ||
| 1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Nimotuzumab
CAS:828933-51-3
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).
Purity:
95.00%
Color and Shape:
Liquid
Ref: TM-T9923
| 1mg | 349.00 € | ||
| 5mg | 1,017.00 € | ||
| 10mg | 1,359.00 € | ||
| 25mg | 2,023.00 € | ||
| 50mg | 2,745.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EGFR-IN-9
CAS:1226549-39-8
EGFR-IN-9 is a potent EGFR kinase inhibitor with IC50s of 7 nM, 28 nM for …
Formula:
C29H24N4O3
Purity:
99.46%
Color and Shape:
Solid
Molecular weight:
476.53
Ref: TM-T11163
| 1mg | 52.00 € | ||
| 5mg | 111.00 € | ||
| 10mg | 170.00 € | ||
| 25mg | 329.00 € | ||
| 50mg | 502.00 € | ||
| 1mL*10mM (DMSO) | 116.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Rezivertinib
CAS:1835667-12-3
Rezivertinib (BPI-7711) is an EGFR inhibitor with antitumor activity and can be used to study …
Formula:
C27H30N6O3
Purity:
99.43% - 99.43%
Color and Shape:
Liquid
Molecular weight:
486.57
Ref: TM-T36644
| 1mg | 99.00 € | ||
| 5mg | 226.00 € | ||
| 10mg | 364.00 € | ||
| 25mg | 702.00 € | ||
| 50mg | 947.00 € | ||
| 100mg | 1,264.00 € | ||
| 200mg | 1,700.00 € | ||
| 1mL*10mM (DMSO) | 47.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Epitinib succinate
CAS:2252334-12-4
Epitinib succinate (HMPL-813 succinate) is an orally active and brain penetration EGFR tyrosine kinase inhibitor …
Formula:
C28H32N6O6
Purity:
97.43% - 99.47%
Color and Shape:
Solid
Molecular weight:
548.59
Ref: TM-T35914
| 1mg | 75.00 € | ||
| 2mg | 97.00 € | ||
| 5mg | 170.00 € | ||
| 10mg | 271.00 € | ||
| 25mg | 449.00 € | ||
| 50mg | 615.00 € | ||
| 100mg | 843.00 € | ||
| 500mg | 1,691.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Nuvenzepine
CAS:96487-37-5
Nuvenzepine is an antagonist of mAChR. It has the potential for gastrospasm treatment.
Formula:
C19H20N4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
336.39
Ref: TM-T16362
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
BKI-1369
CAS:1951431-22-3
BKI-1369 is a bumped kinase inhibitor. BKI-1369 increases hERG-inhibitory activity (IC50:1.52 μM).
Formula:
C23H27N7O
Color and Shape:
Solid
Molecular weight:
417.51
Ref: TM-T10556
| 5mg | 450.00 € | ||
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Selatinib
CAS:1275595-86-2
Selatinib is an orally active and potent dual inhibitor of EGFR and ErbB2 with anticancer …
Formula:
C29H26ClFN4O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
565.06
Ref: TM-T34602
| 1mg | 99.00 € | ||
| 5mg | 235.00 € | ||
| 10mg | 354.00 € | ||
| 25mg | 645.00 € | ||
| 50mg | 938.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
LY 456236 hydrochloride
CAS:338736-46-2
LY 456236 hydrochloride (MPMQ hydrochloride) is an mGlu1 receptor antagonist with an ic50 value of …
Formula:
C16H16ClN3O2
Purity:
99.89%
Color and Shape:
Solid
Molecular weight:
317.77
Ref: TM-T22954
| 1mg | 42.00 € | ||
| 2mg | 35.00 € | ||
| 5mg | 52.00 € | ||
| 10mg | 85.00 € | ||
| 25mg | 164.00 € | ||
| 50mg | 259.00 € | ||
| 100mg | 374.00 € | ||
| 200mg | 522.00 € | ||
| 500mg | 1,293.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Cloperastine fendizoate
CAS:85187-37-7
Cloperastine fendizoate (Hustazol) inhibits the hERG K+ currents in a concentration-dependent manner (IC50: 27 nM).
Formula:
C40H38ClNO5
Purity:
99.85%
Color and Shape:
Solid
Molecular weight:
648.19
Ref: TM-T13619
| 500mg | 49.00 € | ||
| 1mL*10mM (DMSO) | 50.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EMI1
CAS:35773-42-3
EMI1 targets mutated EGFR in drug-resistant NSCLC research.
Formula:
C20H18N2O3
Purity:
100%
Color and Shape:
Liquid
Molecular weight:
334.37
Ref: TM-T61016
| 5mg | 39.00 € | ||
| 10mg | 64.00 € | ||
| 25mg | 117.00 € | ||
| 50mg | 187.00 € | ||
| 100mg | 301.00 € | ||
| 200mg | 425.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
CGP52411
CAS:145915-58-8
CGP52411 is an orally active, and ATP-competitive inhibitor of EGFR (IC50: 0.3 μM).
Formula:
C20H15N3O2
Purity:
99.56%
Color and Shape:
Solid
Molecular weight:
329.35
Ref: TM-T10782
| 1mg | 42.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 120.00 € | ||
| 25mg | 235.00 € | ||
| 50mg | 358.00 € | ||
| 100mg | 553.00 € | ||
| 1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EGFR-IN-16
CAS:133550-22-8
EGFR-IN-16 (AG473) is an inhibitor of EGFR in human A431 cells.
Formula:
C16H11NO3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
265.26
Ref: TM-T8525
| 5mg | 119.00 € | ||
| 10mg | 185.00 € | ||
| 25mg | 351.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EGFR-IN-88
CAS:2944452-34-8
EGFR-IN-88 (Compound 4i), an EGFR inhibitor with an IC50 of 87 nM, exhibits cytotoxic effects …
Formula:
C22H18Cl2N4O2S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
473.37
Ref: TM-T79694
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
EGFR-IN-89
CAS:2413029-40-8
EGFR-IN-89 (compound 13k) is a fourth-generation inhibitor selectively targeting EGFR mutations, exhibiting potent activity with …
Formula:
C26H31FN8O2S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
538.64
Ref: TM-T79775
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
